1,000
Participants
Start Date
February 29, 2012
Primary Completion Date
July 31, 2012
Study Completion Date
January 31, 2013
ELISA testing
Enzyme-linked immuno-assay (ELISA) will be used to determine hepatitis B surface antigen (HBsAg) and anti-HBsAg antibody (anti-HBs Ab) status. Results will be given after test results are available (8-10 days).
Rapid testing
A rapid test will be performed to determine the subjects' hepatitis B surface antigen (HBsAg, using VIKIA®) and anti-HBs antibody status (anti-HBs Ab, using Quick ProfileTM). Results will be given the same day.
Centre de Santé au Maire-Volta, Paris
Centre d'examen de santé de la CPAM, antenne rue du Maroc, Paris
Consultation Policlinique de l'hôpital Saint-Antoine, Paris
Consultation Voyage de l'hôpital Saint-Antoine, Paris
CDAG de Belleville, Paris
Collaborators (2)
ANRS, Emerging Infectious Diseases
OTHER_GOV
Gilead Sciences
INDUSTRY
Roche Pharma AG
INDUSTRY
Mairie de Paris
UNKNOWN
BioMérieux
INDUSTRY
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
OTHER